IDEXX LABORATORIES INC /DE — Director's Dealing 2020

Aug 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-08-20

Reporting Person: JUNIUS DANIEL M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-20	Common Stock	M	3722	$63.95	Acquired	6569	Direct
2020-08-20	Common Stock	S	3722	$382.607	Disposed	2847	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-20	Non-Qualified Stock Option (right-to-buy)	$63.95	M	3722	Disposed	2025-05-05	Common Stock (3722)	Direct

Footnotes

F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,861 shares on May 6, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

F2: Not applicable.